Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Part of paid clinical trials in Oklahoma City, Oklahoma.
- Sponsor
- University of Oklahoma
- Study ID
- NCT04248205
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Hemorrhoids
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ketamine — DRUGStandard general anesthesia PLUS ketamine will be given for post-operative analgesia
Study Details
This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine is administered. The investigators will know whether the participant receives ketamine or not.
Key Dates
- Start date
- Jun 15, 2020
- Status verified
- Mar 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Intraoperative ketamine infusionSubjects in this group will receive standard anesthesia during surgery and a dose of ketamine at 0.3 mg/kg IV bolus prior to surgical incision. If the procedure lasts more than 1 hour, an additional bolus dose will be given.
- No Intervention: Control groupThis group will only receive the standard anesthesia during surgery with no ketamine.
Primary Outcome Measure
Change in post-operative narcotic usage [ Time Frame: two weeks post-operation ]
Central Contacts
- Steven N Carter, MD405-271-8001
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 |
Find similar trials in Oklahoma City, OK
By research site